Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Receivables (2016 - 2025)

Alkermes (ALKS) has disclosed Receivables for 15 consecutive years, with $334.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables fell 14.25% to $334.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $334.0 million, a 14.25% decrease, with the full-year FY2025 number at $334.0 million, down 26.43% from a year prior.
  • Receivables was $334.0 million for Q4 2025 at Alkermes, down from $355.1 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $389.5 million in Q4 2024 to a low of $252.8 million in Q1 2021.
  • A 5-year average of $318.7 million and a median of $324.2 million in 2021 define the central range for Receivables.
  • Peak YoY movement for Receivables: fell 14.32% in 2022, then increased 27.5% in 2023.
  • Alkermes' Receivables stood at $326.6 million in 2021, then fell by 9.08% to $296.9 million in 2022, then rose by 12.22% to $333.2 million in 2023, then increased by 16.91% to $389.5 million in 2024, then decreased by 14.25% to $334.0 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Receivables are $334.0 million (Q4 2025), $355.1 million (Q3 2025), and $356.3 million (Q2 2025).